osteolabs GmbH is an innovative medical diagnostics company from Kiel, Germany.
osteolabs has successfully applied its Calcium Isotope Marker Technology for the early detection of osteoporosis and therapy monitoring with more than 3,600 patient samples analysed from Germany, Switzerland, UK and Europe. The OsteoTest is protected by the international patent application WO 2020/043771A1.
Recent clinical feasibility studies have now demonstrated the possibility for the platform to also detect other metabolic bone disorders.
osteolabs uses ICP MS technology from ThermoFisher Scientific to perform their medical analysis.
Since its start, the company has received a number of prestigious awards including "Germany - Land of Ideas" award in 2017, EARTO Innovation Awards in 2020 and 2023 the Innovation Award of the State Capital Kiel.
osteolabs has offices in Germany and London with further International expansion planned. The company is financed by Venture Capital.